At the tradeshow, Dow featured Dow Corning QP1 Liquid Silicone Rubber, a two-part platinum-catalyzed silicone elastomer for short-term implant and non-implant medical device applications. This offering expands the solution set that Dow Corning currently brings to the healthcare market for medical device and component fabrication. It gives customers the choice to select the most appropriate product to meet their liquid injection molding needs.
Dow Corning also showcased a line of advanced wound dressings, Dow Corning Soft Skin Adhesives. The newest offering, Dow Corning MG7-9900, allows for longer wear due to higher adhesion, while also permitting the dressing to be removed without harming delicate skin.
“Dow Corning’s innovative silicone solutions are designed to address the real challenges facing our nation’s healthcare system, such as the rising costs of medical care, and the needs of an aging population,” said James Stephenson, Dow Corning Healthcare global strategic marketing manager.